J Immunol:TNF反向信号调节炎症反应分子机制

2016-01-11 佚名 生物谷

TNF-a是一类典型的炎性细胞因子,它的前体是一类II型跨膜蛋白(mTNF-a)。成熟的TNF-a能够识别细胞表面的TNF-R1以及TNF-R2,从而使得该类受体的激活与三聚化。类似的,TNF-a前体有两类截然不同的功能:由于mTNF-a在未结合受体的情况下是天然的三聚化结构,一方面它可以像成熟的TNF-a一样与TNF-R结合产生下游信号,另一方面这一结合也可以使其将受体信号反向传递至配体细胞中(

TNF-a是一类典型的炎性细胞因子,它的前体是一类II型跨膜蛋白(mTNF-a)。成熟的TNF-a能够识别细胞表面的TNF-R1以及TNF-R2,从而使得该类受体的激活与三聚化。类似的,TNF-a前体有两类截然不同的功能:由于mTNF-a在未结合受体的情况下是天然的三聚化结构,一方面它可以像成熟的TNF-a一样与TNF-R结合产生下游信号,另一方面这一结合也可以使其将受体信号反向传递至配体细胞中(即相反方向)。之前的研究已经发现mTNF-a的反向信号能够干预LPS对巨噬细胞的激活作用,其中的关键步骤包括ERK的激活。然而,其中的分子机制并不清楚。在最近的一项研究中,来自希腊Debrecen大学的Zsuzsa Szondy课题组阐释了TNF-a反向信号的最新分子机制。相关结果发表在最新一期的Journal of Immunology杂志上。

 
首先,作者希望了解天然免疫细胞表面mTNF-a的表达情况。他们选择了小鼠原代骨髓巨噬细胞以及RAW264.7细胞系进行研究。结果显示,在未激活状态下,两类细胞表面TNF-a有一个本底水平的表达,在受到LPS刺激后,这一表达水平会显著提高。之后,他们发现mTNFa的信号会使得下游MKK3/6、PI3K、MAPK、JNK等激酶的激活。
 
进一步,作者通过real-time PCR的方法证明mTNF-a激活后会使巨噬细胞产生TGF-b。而通过小分子抑制剂分别阻断了下游JNK、ERK、MAPK等激酶的活性。结果显示,在JNK活性被抑制的情况下,mTNF-a引发的TGF-b释放受到了明显的抑制,但p38 MAPK的抑制则没有明显的影响。这一结果说明JNK在mTNF-a的信号传递过程中具有重要的作用。之后,作者证明了mTNF-a通过诱导产生TGF-b能够抑制LPS对巨噬细胞的激活作用。
 
由于临床上有许多针对TNF-a的药物,涵盖了包括肠炎、关节炎等在内的多种免疫疾病。但是这些药物在调节炎症反应的效果上却千差万别。作者根据上述实验的结果推测这一差异可能与TGF-b的含量有一定关系。通过体外培养并刺激人员巨噬细胞,同时加入不同类型的药物。结果显示:那些临床上效果好的药物通常能够引发较多的TGF-b的产生。

原始出处:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1320818, encodeId=2c3a132081838, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jan 13 01:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401620, encodeId=210b1401620e9, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17579, encryptionId=17e21e57943, topicName=TNF)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjVbfRD4f4vibEcZVcvato8Qib1gGtZJiayXCMFgHrkeErSiaxdYMiabKGxY2an9muxWCkUJbjFPViaC6A/132, createdBy=e4fb2361580, createdName=snowpeakxu, createdTime=Wed Jan 13 01:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56465, encodeId=16095646597, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56092, encodeId=c2c256092da, content=信号, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Tue Jan 12 07:29:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55993, encodeId=9ebb55993a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170203/IMG58944A1F6F77F5112.jpg, createdBy=29891665859, createdName=不着调的小师兄, createdTime=Mon Jan 11 17:34:00 CST 2016, time=2016-01-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1320818, encodeId=2c3a132081838, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jan 13 01:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401620, encodeId=210b1401620e9, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17579, encryptionId=17e21e57943, topicName=TNF)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjVbfRD4f4vibEcZVcvato8Qib1gGtZJiayXCMFgHrkeErSiaxdYMiabKGxY2an9muxWCkUJbjFPViaC6A/132, createdBy=e4fb2361580, createdName=snowpeakxu, createdTime=Wed Jan 13 01:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56465, encodeId=16095646597, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56092, encodeId=c2c256092da, content=信号, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Tue Jan 12 07:29:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55993, encodeId=9ebb55993a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170203/IMG58944A1F6F77F5112.jpg, createdBy=29891665859, createdName=不着调的小师兄, createdTime=Mon Jan 11 17:34:00 CST 2016, time=2016-01-11, status=1, ipAttribution=)]
    2016-01-13 snowpeakxu
  3. [GetPortalCommentsPageByObjectIdResponse(id=1320818, encodeId=2c3a132081838, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jan 13 01:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401620, encodeId=210b1401620e9, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17579, encryptionId=17e21e57943, topicName=TNF)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjVbfRD4f4vibEcZVcvato8Qib1gGtZJiayXCMFgHrkeErSiaxdYMiabKGxY2an9muxWCkUJbjFPViaC6A/132, createdBy=e4fb2361580, createdName=snowpeakxu, createdTime=Wed Jan 13 01:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56465, encodeId=16095646597, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56092, encodeId=c2c256092da, content=信号, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Tue Jan 12 07:29:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55993, encodeId=9ebb55993a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170203/IMG58944A1F6F77F5112.jpg, createdBy=29891665859, createdName=不着调的小师兄, createdTime=Mon Jan 11 17:34:00 CST 2016, time=2016-01-11, status=1, ipAttribution=)]
    2016-01-12 huangshang9812

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1320818, encodeId=2c3a132081838, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jan 13 01:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401620, encodeId=210b1401620e9, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17579, encryptionId=17e21e57943, topicName=TNF)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjVbfRD4f4vibEcZVcvato8Qib1gGtZJiayXCMFgHrkeErSiaxdYMiabKGxY2an9muxWCkUJbjFPViaC6A/132, createdBy=e4fb2361580, createdName=snowpeakxu, createdTime=Wed Jan 13 01:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56465, encodeId=16095646597, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56092, encodeId=c2c256092da, content=信号, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Tue Jan 12 07:29:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55993, encodeId=9ebb55993a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170203/IMG58944A1F6F77F5112.jpg, createdBy=29891665859, createdName=不着调的小师兄, createdTime=Mon Jan 11 17:34:00 CST 2016, time=2016-01-11, status=1, ipAttribution=)]
    2016-01-12 老段

    信号

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1320818, encodeId=2c3a132081838, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jan 13 01:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401620, encodeId=210b1401620e9, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17579, encryptionId=17e21e57943, topicName=TNF)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjVbfRD4f4vibEcZVcvato8Qib1gGtZJiayXCMFgHrkeErSiaxdYMiabKGxY2an9muxWCkUJbjFPViaC6A/132, createdBy=e4fb2361580, createdName=snowpeakxu, createdTime=Wed Jan 13 01:21:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56465, encodeId=16095646597, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Tue Jan 12 20:26:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56092, encodeId=c2c256092da, content=信号, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Tue Jan 12 07:29:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55993, encodeId=9ebb55993a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170203/IMG58944A1F6F77F5112.jpg, createdBy=29891665859, createdName=不着调的小师兄, createdTime=Mon Jan 11 17:34:00 CST 2016, time=2016-01-11, status=1, ipAttribution=)]
    2016-01-11 不着调的小师兄

    0

相关资讯

BMC Cancer:中性粒细胞计与前列腺癌患者预后

越来越多的证据表明全身炎症和癌症的发展进展密切相关。中性粒细胞/淋巴细胞比值(NLR)已被证明是多种晚期和局部癌症的独立预后因素。研究组进行了一项研究,探究局限性前列腺癌患者放疗后全身炎症反应如白细胞计数和代谢疾病对总体生存期(OS)的影响。研究者对外部照射或近距离放射治疗后的局部前列腺癌患者进行了一项回顾性研究。使用单变量和多变量Cox比例风险模型评估下列因素对患者生存的影响:年龄、中性粒细胞和

Am Heart J: IL-6和CRP是房颤患者死亡和心血管事件发生的危险因素(RE-LY研究)

背景:炎症与心血管疾病和房颤(AF)相关。这项研究中,研究者评估房颤患者炎症标志物和未来心血管事件的发生的相关性。方法:随机化分析IL-6,CRP(n= 6187)和纤维蛋白原(n = 4893)。应用Cox模型和C-statistics评估预后。结果:校正临床危险因子后,IL-6与卒中或全身性栓塞,严重出血,血管性死亡和复合血栓栓塞预后(缺血性卒中,全身性栓塞,心肌梗死,肺栓塞和血管性死亡)相关

PNAS:肺部炎症微环境可促进癌症肺转移

最近一项研究发现肺部炎症可能会增加其他部位癌症向肺部的扩散。在本周发表在国际学术期刊PNAS上的这项最新研究中,研究人员揭示了炎症促进癌症肺转移的机制,对于肺部炎症如何为癌症向肺部传播提供合适环境进行了着重探讨。这项发现或为治疗以及防止癌症肺转移的发生提供新见解。   科学家们很早就注意到肺部炎症与肺部肿瘤之间存在关联,但是炎症是否会增加其他肿瘤发生肺转移的风险一直没有得到很好的

Hum Reprod Update:生殖障碍的女性拥有更高的不良妊娠结局

背景:生殖障碍和不孕与产科的并发症有相关性,而且对妊娠的结局有负面影响。受影响的患者常常需要借助辅助生殖技术(ART)受孕,高龄产妇的年龄也是进一步的混杂因素。目前的挑战则是剖析因果关系,即决定不孕不育和生殖疾病如何单独或共同影响女性不良妊娠结局,研究其中的相关和混杂因素。方法:检索PubMed上已发表的截止2015年6月的文章,总结所有关于不孕、有生殖障碍的女性的围产儿结局和影响不良妊娠结局的潜

Psychoneuroendocrinology:IL-6较高可预测自杀行为

目的:在抑郁症和其他精神疾病中发现存在免疫功能失调。不太清楚的是,免疫功能失调能影响自杀行为。研究者回顾了自杀意念,自杀行为和自杀相关的细胞因子的文献,并调查了可调节自杀风险炎症的细胞因子与临床和神经生物学因素的相关性。方法:研究者检索了1980至2015年2月PubMed,EMBASE, Scopus和PsycINFO数据库中发表的相关研究。论文包括语言为英文,主要是关于自杀行为患者的细胞因子的

Brain:从大脑炎症中发现阿尔茨海默症的治疗线索

一直到最近,科学家们仍认为阿尔茨海默症干扰了免疫系统,但是小鼠身上的一项新的研究显示,脑部感染或导致了阿尔茨海默症的发生,研究表明阻断调节免疫细胞的一种蛋白或是停止这种脑萎缩性疾病进展的一种方法,该研究结果在线发表于Brain。